Structure-activity studies of hydrophobic amino acid replacements at positions 9, 11 and 16 of glucagon
- 12 January 2009
- journal article
- research article
- Published by Wiley in Chemical Biology & Drug Design
- Vol. 49 (4) , 293-299
- https://doi.org/10.1111/j.1399-3011.1997.tb01129.x
Abstract
We have designed and synthesized eight compounds 2‐9 which incorporate neutral, hydrophobic amino acid residues in positions 9, 11 and 16 of the glucagon molecule: (2) [desHis1,Va19,11e11,16] glucagon amide, (3) [desHis1,Val9,11,16]glucagon amide, (4) [desHis1,Va19,Leu11,16]glucagon amide, (5) [desHis1,Nle9,11e11,16]glucagon amide, (6) [desHis1,Nle9,Val11,16]glucagon amide, (7) [desHis1,Nle9,Leu11,16]glucagon amide, (8) [desHis1,Val9,Leu11,16,Lys17,18,Glu21]glucagon amide and (9) [desHis1,Nle9,Leu11,16,Lys17,18,Glu21]glucagon amide. The effect of neutral, hydrophobic residues at positions 9, 11 and 16 led to good binding to the glucagon receptor. Compared to glucagon (IC50= 1.5 nM), analogues 2‐9 were found to have IC50 values of 6.0, 6.0, 11.0, 9.0, 2.5, 2.8, 6.5 and 7.0 nM, respectively. When these compounds were tested for their ability to block adenylate cyclase (AC) activity, they were found to be antagonists having no stimulation of adenyl cyclase, with PA2, values of 6.15, 6.20, 6.30, 7.25, 6.10, 7.30, 6.25 and 7.25, respectively. © Munksgaard 1997.Keywords
This publication has 17 references indexed in Scilit:
- [des His1, des Phe6, Glu9]glucagon amide: A newly designed “pure” glucagon antagonistBioorganic & Medicinal Chemistry Letters, 1995
- Synthetic glucagon antagonists and partial agonistsInternational Journal of Peptide and Protein Research, 1991
- Design and synthesis of glucagon partial agonists and antagonistsBiochemistry, 1986
- Conformational considerations in the design of a glucagon analog with increased receptor binding and adenylate cyclase potenciesJournal of the American Chemical Society, 1986
- Glucagon in Diabetes MellitusPublished by Springer Nature ,1983
- Role of glucagon in the pathogenesis of diabetes: The status of the controversyMetabolism, 1978
- Structure-function relations in glucagon. Properties of highly purified Des-his1-, monoiodo-, and [Des-Asn28,Thr29](homoserine lactone27)-glucagonBiochemistry, 1975
- THE ESSENTIAL ROLE OF GLUCAGON IN THE PATHOGENESIS OF DIABETES MELLITUSThe Lancet, 1975
- Purification of125I-Glucagon by Anion Exchange ChromatographyHormone and Metabolic Research, 1972
- Isolation of an organ specific protein antigen from cell-surface membrane rat liverBiochimica et Biophysica Acta (BBA) - Protein Structure, 1968